A drug screening is a test that analyzes a biological sample, most commonly urine, to detect the presence of specific drugs or their byproducts in your body. It’s widely used for employment, medical treatment, legal proceedings, and athletic programs. The process typically starts with a quick initial screen, and only samples that come back positive move on to a more precise confirmatory test.
How the Initial Screen Works
The first step in most drug screenings uses a method called immunoassay. In simple terms, your sample is exposed to antibodies designed to latch onto specific drug-related molecules. If those molecules are present above a set threshold, the test flags the result as positive. If they’re below that threshold, the result comes back negative. The result is purely yes or no: the initial screen doesn’t measure how much of a substance is in your system.
This is the same technology used in most home drug test kits and rapid point-of-care tests at clinics. It’s fast, relatively inexpensive, and highly sensitive, meaning it catches most true positives. The trade-off is that it’s not perfectly specific. The antibodies can sometimes react with compounds that are structurally similar to the target drug but are actually something else entirely, which is what causes false positives.
What Drugs Are Tested
The most common version is the 5-panel test, which is the standard for federal and Department of Transportation testing. It screens for five categories:
- Marijuana (THC)
- Cocaine
- Amphetamines (including methamphetamine and MDMA)
- Opioids (including codeine, morphine, heroin metabolites, hydrocodone, oxycodone, and others)
- Phencyclidine (PCP)
Expanded panels, such as a 10-panel or 12-panel test, add categories like benzodiazepines (anti-anxiety medications), barbiturates, and methadone. Employers and clinicians choose the panel based on the situation. A pre-employment screen for a trucking company will follow a different protocol than a screen ordered by a pain management doctor.
Cutoff Levels and What They Mean
A drug screening doesn’t flag every trace of a substance. Each drug category has a cutoff concentration, measured in nanograms per milliliter (ng/mL), that your sample must exceed to register as positive. The federal cutoff levels for an initial screen include 50 ng/mL for marijuana metabolites, 300 ng/mL for cocaine metabolites, 1,000 ng/mL for amphetamines, 300 ng/mL for opiates, and 25 ng/mL for PCP.
These thresholds exist to reduce the chance that incidental or trace exposure triggers a positive result. If your sample falls below the cutoff, it’s reported as negative regardless of whether a tiny amount of the substance is technically present.
What Happens When a Screen Is Positive
A positive initial screen doesn’t automatically mean you’ve used an illegal substance. Because the immunoassay can cross-react with unrelated compounds, a second, more precise test is run on the same sample. This confirmatory test uses a technology called mass spectrometry combined with chromatography. It works by physically separating the chemical components in your sample and then identifying each one by its molecular structure.
This second step is far more specific. It can distinguish between the actual drug and a lookalike molecule, and it can measure the exact concentration. False positives on confirmatory testing are rare. Only after this second analysis confirms the initial result is the test officially reported as positive.
Common Causes of False Positives
Several prescription and over-the-counter medications are known to trigger false positives on the initial screen. Certain antibiotics in the quinolone family can cross-react with the opioid panel. Diphenhydramine, the active ingredient in many allergy and sleep medications, and doxylamine, found in some nighttime cold formulas, can trigger false positives on methadone-specific screens. The blood pressure medication verapamil, the antibiotic rifampin, and the antipsychotic quetiapine have also been documented to cause false-positive results. Even poppy seeds, which contain trace amounts of naturally occurring opiates, can push a sample above the screening threshold.
This is exactly why confirmatory testing exists. If you’re taking a medication that could cross-react, that second-step analysis will almost always clear it up. In regulated testing programs, a physician called a Medical Review Officer reviews every positive result and contacts you to ask about prescriptions or other explanations before the result is finalized.
Sample Types and Detection Windows
Urine is by far the most common sample type for drug screening, but blood, saliva, and hair are also used depending on the context. Each sample type detects substances over a different time window. Urine generally reflects use within the past few days for most drugs, though heavy or chronic marijuana use can remain detectable for weeks. Blood testing captures a shorter window, typically hours to a couple of days, reflecting more recent use. Saliva testing is similar to blood in its detection window and is sometimes used for roadside or workplace testing because collection is less invasive. Hair testing captures the longest window, potentially showing drug use over the previous 90 days, since drug metabolites get deposited in the hair shaft as it grows.
The choice of sample type depends on what the tester wants to know. An employer conducting a pre-employment screen usually wants a urine test. An emergency room physician may order a blood test to understand what’s affecting a patient right now. A court-ordered monitoring program may use hair testing to look for patterns over months.
The Collection Process
For workplace and legal screenings, the collection process follows strict rules to prevent tampering and ensure the sample can hold up to scrutiny. In federally regulated programs, every collection is documented on a Custody and Control Form that tracks the sample from the moment it leaves your body to the moment the lab reports a result. The collector records the actual location of the collection, provides a direct phone number for follow-up questions, and ensures the sample is sealed and labeled in your presence.
You’ll typically provide your sample in a private restroom, though the collector may note the temperature of the sample immediately after collection to confirm it’s fresh. The sealed specimen is then sent to a certified laboratory. For clinical screenings in a medical setting, the process is generally less formal, though the testing technology is the same.
Workplace vs. Clinical Screening
The purpose of the screening shapes nearly everything about how it’s conducted. Workplace drug screens are designed to be legally defensible. They use certified labs, chain-of-custody documentation, and Medical Review Officers. The goal is to produce a result that can withstand a legal challenge if an employee disputes it. Federal employees, transportation workers, and many private-sector employees are subject to this type of testing before hire, after workplace accidents, or on a random basis.
Clinical drug screening, on the other hand, is a medical tool. Doctors use it to monitor patients in pain management programs, to assess substance use in psychiatric evaluations, or to guide treatment decisions in emergency settings. The emphasis is on getting useful clinical information quickly rather than building a legal record. Consent, documentation, and lab standards may differ significantly from the workplace model, though the underlying science is the same.